I don't consider myself as the type of investor wh
Post# of 30028
Posted On: 07/17/2014 8:56:50 PM
I don't consider myself as the type of investor who closes his eyes when concerns are raised. But if I have a concern, I don't look for answers on the message board. I go to the source... Gerald.
Some here spent 3 days agonizing over their lack of understanding of the data released on Tuesday... hundreds of posts back and forth on various boards trying to resolve the same issue, which in fact wasn't an issue at all. I'm sure this confusion sparked the village idiot to begin his 24 hour rampage attacking the data, knowing it would fuel the flames and cause even more fear among shareholders that Gerald might be misleading us by trying to sugarcoat bad LymPro data.
Yes, I get a little rankled when I see long shareholders fretting and bitching about how Gerald deceived them, and how he appears to be avoiding the question of the 160 subject testing, when in fact no such test ever existed. I never saw a single post where those questioning this ever attempted to contact Gerald to clarify. Instead their overanalysis of a nonexistent problem caused everyone concern and flared tempers, including mine.
The lesson that everyone should learn here is to GO TO THE SOURCE when there is a question or concern. Fire off a brief email to Gerald to clarify something. He has demonstrated he will respond if it's something he can answer. Gerald will set things straight, if we only ask.
Seriously, if anyone believes our CEO is trying to deceive them, please have the balls to sell your shares and move on.
Some here spent 3 days agonizing over their lack of understanding of the data released on Tuesday... hundreds of posts back and forth on various boards trying to resolve the same issue, which in fact wasn't an issue at all. I'm sure this confusion sparked the village idiot to begin his 24 hour rampage attacking the data, knowing it would fuel the flames and cause even more fear among shareholders that Gerald might be misleading us by trying to sugarcoat bad LymPro data.
Yes, I get a little rankled when I see long shareholders fretting and bitching about how Gerald deceived them, and how he appears to be avoiding the question of the 160 subject testing, when in fact no such test ever existed. I never saw a single post where those questioning this ever attempted to contact Gerald to clarify. Instead their overanalysis of a nonexistent problem caused everyone concern and flared tempers, including mine.
The lesson that everyone should learn here is to GO TO THE SOURCE when there is a question or concern. Fire off a brief email to Gerald to clarify something. He has demonstrated he will respond if it's something he can answer. Gerald will set things straight, if we only ask.
Seriously, if anyone believes our CEO is trying to deceive them, please have the balls to sell your shares and move on.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼